WallStreetZenWallStreetZen

NASDAQ: GEHC
Ge Healthcare Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GEHC

Based on 6 analysts offering 12 month price targets for Ge Healthcare Technologies Inc

Min Forecast
$80.00-3.65%
Avg Forecast
$85.83+3.38%
Max Forecast
$92.00+10.8%

Should I buy or sell GEHC stock?

Based on 6 analysts offering ratings for Ge Healthcare Technologies Inc.

Buy
Strong Buy
2 analysts 33.33%
Buy
1 analysts 16.67%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GEHC's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates GEHC as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GEHC stock forecasts and price targets.

GEHC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-21
lockedlocked$00.00+00.00%2025-10-30
lockedlocked$00.00+00.00%2025-10-30
lockedlocked$00.00+00.00%2025-10-30
lockedlocked$00.00+00.00%2025-10-13
Citigroup
Top 7%
94
HoldDowngrades$83.00-0.04%2025-10-07

1 of 1

Forecast return on equity

Is GEHC forecast to generate an efficient return?

Company
27.89%
Industry
20.25%
Market
227.38%
GEHC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GEHC forecast to generate an efficient return on assets?

Company
7.71%
Industry
16.8%
GEHC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GEHC earnings per share forecast

What is GEHC's earnings per share in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$4.61-5%
Avg 2 year Forecast
$5.01+3.31%
Avg 3 year Forecast
$5.59+15.35%
GEHC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GEHC revenue forecast

What is GEHC's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$20.9B+3.31%
Avg 2 year Forecast
$21.8B+7.84%
Avg 3 year Forecast
$22.8B+12.64%
GEHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GEHC earnings growth forecast

How is GEHC forecast to perform vs Health Information Services companies and vs the US market?

Company
4.66%
Industry
32.13%
Market
42.62%
GEHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GEHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GEHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GEHC revenue growth forecast

How is GEHC forecast to perform vs Health Information Services companies and vs the US market?

Company
4.03%
Industry
9.7%
Market
25.81%
GEHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GEHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GEHC vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
GEHC$83.03$85.83+3.38%Buy
VEEV$232.00$314.91+35.73%Buy
SOLV$80.11$90.33+12.76%Buy
TEM$75.88$89.88+18.44%Strong Buy
DOCS$45.13$68.00+50.68%Buy
View Top Health Information Service Stocks

Ge Healthcare Technologies Stock Forecast FAQ

Is Ge Healthcare Technologies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: GEHC) stock is to Buy GEHC stock.

Out of 6 analysts, 2 (33.33%) are recommending GEHC as a Strong Buy, 1 (16.67%) are recommending GEHC as a Buy, 3 (50%) are recommending GEHC as a Hold, 0 (0%) are recommending GEHC as a Sell, and 0 (0%) are recommending GEHC as a Strong Sell.

If you're new to stock investing, here's how to buy Ge Healthcare Technologies stock.

What is GEHC's earnings growth forecast for 2025-2027?

(NASDAQ: GEHC) Ge Healthcare Technologies's forecast annual earnings growth rate of 4.66% is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 32.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.62%.

Ge Healthcare Technologies's earnings in 2025 is $2,217,000,000.On average, 24 Wall Street analysts forecast GEHC's earnings for 2025 to be $2,098,770,183, with the lowest GEHC earnings forecast at $1,772,252,306, and the highest GEHC earnings forecast at $2,195,386,313. On average, 24 Wall Street analysts forecast GEHC's earnings for 2026 to be $2,282,390,937, with the lowest GEHC earnings forecast at $1,946,352,658, and the highest GEHC earnings forecast at $2,458,450,032.

In 2027, GEHC is forecast to generate $2,548,415,546 in earnings, with the lowest earnings forecast at $2,223,127,578 and the highest earnings forecast at $2,769,343,519.

What is GEHC's revenue growth forecast for 2025-2027?

(NASDAQ: GEHC) Ge Healthcare Technologies's forecast annual revenue growth rate of 4.03% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.

Ge Healthcare Technologies's revenue in 2025 is $20,246,000,000.On average, 24 Wall Street analysts forecast GEHC's revenue for 2025 to be $9,528,145,139,864, with the lowest GEHC revenue forecast at $9,007,939,481,800, and the highest GEHC revenue forecast at $9,865,231,117,944. On average, 24 Wall Street analysts forecast GEHC's revenue for 2026 to be $9,945,858,439,728, with the lowest GEHC revenue forecast at $9,422,008,608,928, and the highest GEHC revenue forecast at $10,456,498,144,360.

In 2027, GEHC is forecast to generate $10,388,169,905,560 in revenue, with the lowest revenue forecast at $9,765,016,367,704 and the highest revenue forecast at $10,995,835,709,288.

What is GEHC's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: GEHC) forecast ROA is 7.71%, which is lower than the forecast US Health Information Services industry average of 16.8%.

What is GEHC's Price Target?

According to 6 Wall Street analysts that have issued a 1 year GEHC price target, the average GEHC price target is $85.83, with the highest GEHC stock price forecast at $92.00 and the lowest GEHC stock price forecast at $80.00.

On average, Wall Street analysts predict that Ge Healthcare Technologies's share price could reach $85.83 by Nov 21, 2026. The average Ge Healthcare Technologies stock price prediction forecasts a potential upside of 3.38% from the current GEHC share price of $83.03.

What is GEHC's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GEHC) Ge Healthcare Technologies's current Earnings Per Share (EPS) is $4.85. On average, analysts forecast that GEHC's EPS will be $4.61 for 2025, with the lowest EPS forecast at $3.89, and the highest EPS forecast at $4.82. On average, analysts forecast that GEHC's EPS will be $5.01 for 2026, with the lowest EPS forecast at $4.27, and the highest EPS forecast at $5.40. In 2027, GEHC's EPS is forecast to hit $5.59 (min: $4.88, max: $6.08).

What is GEHC's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: GEHC) forecast ROE is 27.89%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.